Literature DB >> 32676541

Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights.

Christopher R McCartney1, Rebecca E Campbell2.   

Abstract

Although the fundamental symptoms of polycystic ovary syndrome (PCOS) relate most directly to ovarian dysfunction, central neuroendocrine systems play a prominent role in its pathophysiology. Gonadotropin-releasing hormone (GnRH) pulse generator resistance to negative feedback contributes to rapid GnRH pulse secretion, which promotes gonadotropin abnormalities that foster ovarian hyperandrogenemia and ovulatory dysfunction. The causes of GnRH neuron dysfunction, however, have remained enigmatic. In this review, we highlight a number of recent preclinical and clinical studies pertinent to the neuroendocrine abnormalities of PCOS, including those that have provided important insights into the relevance of animal models with PCOS-like features, the potential roles of kisspeptin and γ-aminobutyric acid (GABA)-ergic neurons, and the potential role of anti-Müllerian hormone.

Entities:  

Year:  2020        PMID: 32676541      PMCID: PMC7365617          DOI: 10.1016/j.coemr.2020.04.005

Source DB:  PubMed          Journal:  Curr Opin Endocr Metab Res        ISSN: 2451-9650


  67 in total

1.  The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep.

Authors:  Guanliang Cheng; Lique M Coolen; Vasantha Padmanabhan; Robert L Goodman; Michael N Lehman
Journal:  Endocrinology       Date:  2009-10-30       Impact factor: 4.736

2.  Prenatal Testosterone Treatment Leads to Changes in the Morphology of KNDy Neurons, Their Inputs, and Projections to GnRH Cells in Female Sheep.

Authors:  Maria Cernea; Vasantha Padmanabhan; Robert L Goodman; Lique M Coolen; Michael N Lehman
Journal:  Endocrinology       Date:  2015-06-10       Impact factor: 4.736

Review 3.  Kisspeptin and Polycystic Ovary Syndrome.

Authors:  Rong Tang; Xiaohong Ding; Jianghu Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-10       Impact factor: 5.555

4.  Serum Anti-Müllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses.

Authors:  Laura Detti; Mary E Christiansen; Ludwig Francillon; Gini Ikuwezunma; Michael P Diamond; Giancarlo Mari; Ana M Tobiasz
Journal:  Syst Biol Reprod Med       Date:  2018-11-14       Impact factor: 3.061

5.  Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.

Authors:  D H Abbott; B H Rayome; D A Dumesic; K C Lewis; A K Edwards; K Wallen; M E Wilson; S E Appt; J E Levine
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

6.  Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women.

Authors:  Blazej Meczekalski; Krzysztof Katulski; Agnieszka Podfigurna-Stopa; Adam Czyzyk; Alessandro D Genazzani
Journal:  Fertil Steril       Date:  2016-02-06       Impact factor: 7.329

7.  Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood.

Authors:  Alison V Roland; Suzanne M Moenter
Journal:  Endocrinology       Date:  2010-12-15       Impact factor: 4.736

8.  Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.

Authors:  Ritu Deswal; Smiti Nanda; Amita Suneja Dang
Journal:  Syst Biol Reprod Med       Date:  2019-04-08       Impact factor: 3.061

9.  Prenatal androgen excess enhances stimulation of the GNRH pulse in pubertal female rats.

Authors:  Xiaonan Yan; Chun Yuan; Nannan Zhao; Yugui Cui; Jiayin Liu
Journal:  J Endocrinol       Date:  2014-05-14       Impact factor: 4.286

10.  A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study.

Authors:  Roy Homburg; Anil Gudi; Amit Shah; Alison M Layton
Journal:  Reprod Biol Endocrinol       Date:  2017-08-08       Impact factor: 5.211

View more
  7 in total

Review 1.  Polycystic Ovary Syndrome: Ontogeny in Adolescence.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Endocrinol Metab Clin North Am       Date:  2021-01-11       Impact factor: 4.741

Review 2.  Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms.

Authors:  Alexander O Shpakov
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-08

3.  Acute progesterone feedback on gonadotropin secretion is not demonstrably altered in estradiol-pretreated women with polycystic ovary syndrome.

Authors:  Su Hee Kim; Jessica A Lundgren; James T Patrie; Christine M Burt Solorzano; Christopher R McCartney
Journal:  Physiol Rep       Date:  2022-04

Review 4.  Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome.

Authors:  Dongxu Wang; Bing He
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-24       Impact factor: 3.249

Review 5.  Endometriosis and polycystic ovary syndrome are diametric disorders.

Authors:  Natalie L Dinsdale; Bernard J Crespi
Journal:  Evol Appl       Date:  2021-05-14       Impact factor: 4.929

Review 6.  Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome.

Authors:  Florentina Duică; Cezara Alina Dănilă; Andreea Elena Boboc; Panagiotis Antoniadis; Carmen Elena Condrat; Sebastian Onciul; Nicolae Suciu; Sanda Maria Creţoiu; Valentin Nicolae Varlas; Dragoş Creţoiu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

Review 7.  Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.

Authors:  Valeria Calcaterra; Elvira Verduci; Hellas Cena; Vittoria Carlotta Magenes; Carolina Federica Todisco; Elisavietta Tenuta; Cristina Gregorio; Rachele De Giuseppe; Alessandra Bosetti; Elisabetta Di Profio; Gianvincenzo Zuccotti
Journal:  Nutrients       Date:  2021-05-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.